Expert Ratings for Renalytix
Portfolio Pulse from Benzinga Insights
In the last quarter, Renalytix (NASDAQ:RNLX) received 5 bullish ratings from analysts. The company has an average 12-month price target of $4.7, representing a 21.67% decrease from the previous average price target of $6.00.
June 30, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Renalytix received 5 bullish ratings from analysts in the last quarter. The average 12-month price target is $4.7, a 21.67% decrease from the previous target.
The decrease in the average 12-month price target for Renalytix indicates a negative sentiment from analysts, which could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100